Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SHE:300760)
China
· Delayed Price · Currency is CNY 233.10
+9.10 (4.06%)
May 13, 2025, 11:44 AM CST
SHE:300760 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 35,488 | 36,624 | 34,875 | 30,354 | 25,258 | 20,981 | Upgrade
|
| Other Revenue | 101.68 | 101.68 | 56.61 | 11.83 | 11.73 | 44.89 | Upgrade
|
| Revenue | 35,590 | 36,726 | 34,932 | 30,366 | 25,270 | 21,026 | Upgrade
|
| Revenue Growth (YoY) | -0.97% | 5.13% | 15.04% | 20.17% | 20.18% | 27.00% | Upgrade
|
| Cost of Revenue | 13,497 | 13,767 | 12,768 | 10,956 | 8,967 | 7,459 | Upgrade
|
| Gross Profit | 22,093 | 22,959 | 22,164 | 19,410 | 16,303 | 13,566 | Upgrade
|
| Selling, General & Admin | 6,611 | 6,883 | 6,534 | 6,122 | 5,105 | 4,509 | Upgrade
|
| Research & Development | 3,485 | 3,666 | 3,433 | 2,923 | 2,524 | 1,869 | Upgrade
|
| Other Operating Expenses | -173.45 | -261.66 | -308.79 | -80.36 | -83.14 | -100.81 | Upgrade
|
| Operating Expenses | 10,256 | 10,586 | 9,903 | 9,001 | 7,539 | 6,307 | Upgrade
|
| Operating Income | 11,837 | 12,373 | 12,261 | 10,409 | 8,764 | 7,259 | Upgrade
|
| Interest Expense | -19.94 | -19.41 | -13 | -10.69 | -8.63 | - | Upgrade
|
| Interest & Investment Income | 647.55 | 626.87 | 821.64 | 357.91 | 408.14 | 385.7 | Upgrade
|
| Earnings From Equity Investments | - | - | - | - | - | -4.47 | Upgrade
|
| Currency Exchange Gain (Loss) | -51.28 | -51.28 | 119.17 | 171.96 | -227.66 | -253.4 | Upgrade
|
| Other Non Operating Income (Expenses) | 47.81 | -87.45 | -72.51 | -67.82 | -85.92 | -70.86 | Upgrade
|
| EBT Excluding Unusual Items | 12,462 | 12,842 | 13,117 | 10,860 | 8,850 | 7,316 | Upgrade
|
| Gain (Loss) on Sale of Investments | -13.6 | 109.33 | 69.56 | -26.44 | 9.88 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 3.48 | 4.24 | 2.46 | 6.16 | 4.07 | -2.07 | Upgrade
|
| Asset Writedown | -1.19 | -1.75 | -274.92 | -0.74 | -7.47 | -16.87 | Upgrade
|
| Legal Settlements | -14.25 | -14.25 | -12.65 | -3.3 | -5.7 | -2.45 | Upgrade
|
| Other Unusual Items | 80.25 | 80.25 | 109.68 | 117.5 | 166.78 | 143.74 | Upgrade
|
| Pretax Income | 12,516 | 13,020 | 13,011 | 10,954 | 9,017 | 7,438 | Upgrade
|
| Income Tax Expense | 1,245 | 1,280 | 1,433 | 1,343 | 1,013 | 778.84 | Upgrade
|
| Earnings From Continuing Operations | 11,271 | 11,740 | 11,578 | 9,611 | 8,004 | 6,660 | Upgrade
|
| Minority Interest in Earnings | -133.56 | -71.48 | 3.81 | -3.54 | -2.49 | -1.93 | Upgrade
|
| Net Income | 11,137 | 11,668 | 11,582 | 9,607 | 8,002 | 6,658 | Upgrade
|
| Net Income to Common | 11,137 | 11,668 | 11,582 | 9,607 | 8,002 | 6,658 | Upgrade
|
| Net Income Growth | -8.49% | 0.74% | 20.56% | 20.07% | 20.18% | 42.24% | Upgrade
|
| Shares Outstanding (Basic) | 1,211 | 1,211 | 1,212 | 1,210 | 1,215 | 1,216 | Upgrade
|
| Shares Outstanding (Diluted) | 1,211 | 1,211 | 1,212 | 1,210 | 1,215 | 1,216 | Upgrade
|
| Shares Change (YoY) | -0.06% | -0.04% | 0.11% | -0.36% | -0.07% | - | Upgrade
|
| EPS (Basic) | 9.19 | 9.64 | 9.56 | 7.94 | 6.59 | 5.48 | Upgrade
|
| EPS (Diluted) | 9.19 | 9.63 | 9.56 | 7.94 | 6.59 | 5.48 | Upgrade
|
| EPS Growth | -8.44% | 0.79% | 20.42% | 20.50% | 20.28% | 42.24% | Upgrade
|
| Free Cash Flow | 9,007 | 10,473 | 8,373 | 10,226 | 7,596 | 7,687 | Upgrade
|
| Free Cash Flow Per Share | 7.43 | 8.65 | 6.91 | 8.45 | 6.25 | 6.32 | Upgrade
|
| Dividend Per Share | 6.270 | 6.270 | 5.800 | 4.500 | 3.500 | 2.500 | Upgrade
|
| Dividend Growth | 8.10% | 8.10% | 28.89% | 28.57% | 40.00% | 66.67% | Upgrade
|
| Gross Margin | 62.08% | 62.51% | 63.45% | 63.92% | 64.52% | 64.52% | Upgrade
|
| Operating Margin | 33.26% | 33.69% | 35.10% | 34.28% | 34.68% | 34.52% | Upgrade
|
| Profit Margin | 31.29% | 31.77% | 33.16% | 31.64% | 31.66% | 31.66% | Upgrade
|
| Free Cash Flow Margin | 25.31% | 28.52% | 23.97% | 33.67% | 30.06% | 36.56% | Upgrade
|
| EBITDA | 13,256 | 13,687 | 13,158 | 11,188 | 9,380 | 7,731 | Upgrade
|
| EBITDA Margin | 37.25% | 37.27% | 37.67% | 36.84% | 37.12% | 36.77% | Upgrade
|
| D&A For EBITDA | 1,419 | 1,314 | 896.04 | 779.11 | 616.47 | 472.12 | Upgrade
|
| EBIT | 11,837 | 12,373 | 12,261 | 10,409 | 8,764 | 7,259 | Upgrade
|
| EBIT Margin | 33.26% | 33.69% | 35.10% | 34.28% | 34.68% | 34.52% | Upgrade
|
| Effective Tax Rate | 9.95% | 9.83% | 11.01% | 12.26% | 11.24% | 10.47% | Upgrade
|
| Revenue as Reported | 35,590 | 36,726 | 34,932 | 30,366 | 25,270 | - | Upgrade
|
| Advertising Expenses | - | 332.39 | 359.41 | 288.69 | 223.68 | 243.39 | Upgrade
|
Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.